<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160508027793N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-09-12</date_registration>
      <primary_sponsor>Hamedan University of Medical Sciences</primary_sponsor>
      <public_title>The   IV Ondansetron on analgesic effects of  IV Acetaminophen after pediatric tonsillectomy</public_title>
      <acronym></acronym>
      <scientific_title>The effect of  IV Ondansetron on analgesic effects of  IV Acetaminophen after pediatric tonsillectomy: a double blinded randomized clinical  trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-08-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/41333</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: For this purpose we will use the Quadratic Block Randomization method. For this purpose, we provide four sheets of paper.
On the two sheets the letter I means "Intervention" and on the other two sheets the letter C means "Comparison". Mix the sheets together and place in a drawer. On referral to each eligible patient, one leaflet will be randomly drawn and based on this leaflet, whether I or C, will be assigned to one of the intervention groups receiving ondansetron and acetaminophen or a comparison of acetaminophen recipients.  It should be noted that the sheets that have been drawn out will not be returned to the drawer until they have been drawn out. After randomly pulling out all four sheets of all four sheets, all the sheets are returned to the drawer again and the procedure will continue again for the next four patients until the desired sample size is reached, Blinding description: In both intervention and control groups, intravenous acetaminophen will be prescribed 2 minutes before surgery, so the patient will not be informed of the prescription drug. Medications are provided by a technician so the anesthesiologist who will measure and record the outcome of the study will not be aware of the type of medication prescribed. In addition, the analyzer will not know the results of the coding of the intervention and comparison groups. Therefore, the study will be conducted in a triple blind manner.</study_design>
      <phase>3</phase>
      <hc_freetext>Chronic tonsillitis and adenoiditis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intravenous ondansetron 0.1 mg / kg in 2 ml volume plus intravenous acetaminophen 15 mg / kg 15 minutes before surgery and acetaminophen suppository every 6 hours to 24 hours after surgery. Intervention 2: Control group: Intravenous normal saline 2 ml plus acetaminophen 2 mg / kg 15 min before end of surgery  and acetaminophen suppository every 6 hours to 24 hours.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Mean pain score

When:
From 2018 to 12019

To whom:
Researchers working in academic and scientific institutions

Conditions:
statistic analysis

Where to obtain:
Dr. Mahshid Nikooseresht
 Niko_mahshid@yahoo.com

How to obtain:
Send email to assistance professor

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Leyla Halimi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>N37 , Ettehad Ally Zolfaghar street , Fatemieh Blv Besat Sq Hamedan , Iran</address>
        <city>Hamedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6515934715</zip>
        <telephone>+98 81 3838 0032</telephone>
        <email>lhhalimi20@yahoo.com</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mahshid Nikooseresht</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>in front of Mardom's Park, Pazhuhesh`s crossroad</address>
        <city>Hamedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6517619664</zip>
        <telephone>+98 81 3838 0574</telephone>
        <email>Niko_mahshid@yahoo.com</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria :• Age 4-5 years:
Candidate for elective adenotonsillectomy
• Parental consent•
• No history of psychiatric illness
• Do not use the apparatus 2 hours before surgery
• Insensitivity to ondansetron or acetaminophen
• No history of venous hepatic disease</inclusion_criteria>
      <agemin>3 years</agemin>
      <agemax>12 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>• Failure to cooperate after initial interventions
• Failure to show proper pain level
• The patient has a decreased level of consciousness.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>J35.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Chronic tonsillitis and adenoiditis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intravenous ondansetron 0.1 mg / kg in 2 ml volume plus intravenous acetaminophen 15 mg / kg 15 minutes before surgery and acetaminophen suppository every 6 hours to 24 hours after surgery</i_keyword>
      <i_keyword>Control group: Intravenous normal saline 2 ml plus acetaminophen 2 mg / kg 15 min before end of surgery  and acetaminophen suppository every 6 hours to 24 hours</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Painless. Timepoint: 15 minutes before surgery and every 6 hours to 24 hours. Method of measurement: Children's hospital Eastern Ontario Pain Scale (ChEOPS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Nausea and vomiting. Timepoint: Four times at recovery, 6 hours, 12 hours and 24 hours after surgery. Method of measurement: ask.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Hamedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-08-14</approval_date>
        <contact_name>Ethics committee of Hamedan University of Medical Sciences</contact_name>
        <contact_address>Opposite of Mardom`s Park  , Pazhuhesh crossroad Hameedan Hamadan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
